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Abstract
Purpose. The development and updating of high-quality clinical practice guidelines require substantial resources. Many guide-
line programmes throughout the world are using similar strategies to achieve similar goals, resulting in many guidelines on the
same topic. One method of using resources more efficiently and avoiding unnecessary duplication of effort would be to adapt
existing guidelines. The aim was to review the literature on adaptation of guidelines and to propose a systematic approach for
adaptation of guidelines.
Data sources. We selected and reviewed reports describing the methods and results of adaptation of guidelines from those
found by searching Medline, Internet, and reference lists of relevant papers. On the basis of this review and our experience in
guideline development, we proposed a conceptual framework and procedure for adaptation of guidelines.
Results. Adaptation of guidelines is performed either as an alternative to de novo guideline development or to improve guide-
line implementation through local tailoring of an international or national guideline. However, no validated process for the
adaptation of guidelines produced in one cultural and organizational setting for use in another (i.e. trans-contextual adaptation)
was found in the literature. The proposed procedure is a stepwise approach to trans-contextual adaptation, including searching
for existing guidelines, quality appraisal, detailed analysis of the coherence between the evidence and the recommendations,
and adaptation of the recommendations to the target context of use, taking into account the organization of the health care sys-
tem and cultural context.
Conclusions. Trans-contextual adaptation of guidelines is increasingly being considered as an alternative to de novo guideline
development. The proposed approach should be validated and evaluated to determine if it can reduce duplication of effort and
inefficient use of resources, although guaranteeing a high-quality product, compared with de novo development.
Keywords: adaptation, clinical practice guidelines, literature review
Clinical practice guidelines are increasingly proposed to
improve the quality of patient care in all areas of medicine [1,2].
The systematic identification and critical analysis of evidence
are the most costly and time-consuming components in the
guideline development process. A large number of organiza-
tions worldwide produce guidelines on similar topics, but sev-
eral studies have suggested that the quality of published
guidelines is highly variable [3–8]. It has been suggested that
unnecessary duplication of effort could be avoided if existing
guidelines were adapted rather than developed de novo [9].
However, the cultural and organizational differences between
countries can lead to legitimate variations in recommendations,
even if the evidence based is the same [10–14]. This means that
guidelines produced in one setting may not necessarily be
appropriate for another, without modification. Such modifica-
tion processes have been referred to under the concept of
‘guideline adaptation’ between different care settings. Little
research has been reported on methods for adapting guide-
lines. In the framework of a project aimed at adapting French
guidelines on the treatment of colon and ovarian cancer for use
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in Quebec, we, the ADAPTE Working Group, performed a
systematic review of the literature on guideline adaptation, and
on the basis of these results, we propose a step-wise, structured
approach for the adaptation of guidelines.
Methods
The ADAPTE Working Group
The ADAPTE Working Group was initiated during a col-
laborative project between the French National Federation
of Comprehensive Cancer Centres (Fédération Nationale
des Centres de Lutte Contre le Cancer; FNCLCC) and the
Quebec Cancer Control Department (Direction de la lutte
contre le cancer). The original aim of the project was to
examine how the FNCLCC guidelines (Standards,
Options, Recommendations; SOR) could be adapted for
use in French-speaking Quebec. The current composition
of the ADAPTE Group is available at www.adapte.org.
Data sources
We searched PubMed (from 1966 to March 2005), and the
National Guideline Clearinghouse and the G-I-N data-
bases. In addition, we searched the reference lists of relev-
ant papers to identify reports on adaptation of clinical
practice guidelines. For PubMed, we combined the MeSH
terms guidelines and practice guidelines and the publication
types guideline and practice guideline with guideline in title and
abstract and the following free-text search terms: adapt*
and tailor*.
We selected all reports that described and assessed adapta-
tion of guidelines. We excluded reports focussing on adapta-
tion of tools and materials other than clinical practice
guidelines (quality of life instruments, questionnaires). Three
of the authors (BF, MH, and JB) independently assessed the
selected reports and retrieved the following information:
objectives of adaptation, setting, disease area, and steps of the
adaptation process covered. Any differences were resolved by
discussion between the assessors.
Proposition for a procedure for guideline 
adaptation
The ADAPTE Working Group had four face-to-face meet-
ings and held bi-monthly telephone conferences to discuss
the results from the literature review and to propose a step-
wise, structured approach to guideline adaptation. This
approach was refined, taking into account discussions during
the meetings. In addition, a group of 16 oncologists and phar-
macists from Quebec were asked to comment on some
selected steps in the process. Their comments were collected
using specifically designed forms and during telephone con-
ferences. After discussion about their comments, the
ADAPTE Working Group modified the procedure to reflect
these comments.
Results
Analysis of the literature
From the 1044 publications retrieved, we identified 18 that
reported models, practical examples, and/or experiences of
guideline adaptation (Table 1). In addition, we selected
another nine publications; six were general discussion papers
[9,15–19] and three focussed on the process of gathering data
for cultural tailoring of guidelines for prevention [20–22]. In
addition, during the preparation of this manuscript, another
publication was identified [23].
Further analysis revealed different objectives for under-
taking guideline adaptation. In 11 of the 18 selected publi-
cations, the objective of guideline adaptation was to
modify an existing guideline for use, where the source
guideline was developed in a distinct cultural and organiza-
tional setting. In four, this was as an alternative to de novo
guideline development [18,23–25], and in the others, this
was for the implementation of guidelines produced in
another country or internationally, and therefore requiring
adaptation to the context in the target setting [26–33]. In
the remaining seven articles, the primary objective of adap-
tation was to improve CPG implementation through tai-
loring of a national guideline to a narrower regional or
local context [34–40]. There were two reports of rand-
omized clinical trials to assess the impact of local adapta-
tion of national guidelines [31,39].
The stages of the adaptation processes described in these
publications could be grouped into six steps (Table 1):
1. Search for existing guidelines;
2. Assessment of guideline quality;
3. Assessment of applicability and adaptation of recom-
mendations to target setting;
4. Literature update;
5. Adaptation of guideline format; and
6. Implementation.
The four reports describing adaptation as an alternative to
a de novo development process involved at least five of these
steps [18,23–25]. These reports started their process with a
search for existing source CPGs, whereas the other reports
started the process with a pre-selected CPG without provid-
ing details of how the guideline to be adapted was selected.
These reports were also the only ones to include a quality
assessment of relevant guidelines [18,23–25]. Three of these
studies used the Appraisal Instrument for Clinical Practice
Guidelines [18,23,24], and the other used the AGREE
instrument [25].
Eight of the publications reported experiences of adapting
guidelines produced either internationally or in another
country for implementation [26–33]. The seven remaining
publications reported adaptation of national guidelines as
part of an implementation process, and these discussed par-
ticularly how the local context was taken into consideration.
Two of these reported results from randomized clinical trials
to assess the impact of local adaptation of national guidelines
[31,39].
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Proposition for a conceptual framework and 
adaptation process
The ADAPTE Working Group is particularly interested in the
adaptation of guidelines produced in one setting for use in
another, either as an alternative to de novo guideline develop-
ment or in the context of implementation of an international or
national guideline. We call this ‘trans-contextual adaptation’.
However, no systematic, validated approach to this type of adap-
tation has been described in the literature. Most of the reports
reviewed were case studies, and their results are difficult to gen-
eralize. On the basis of this literature analysis and our experience
in guideline development, the ADAPTE Working Group has
designed an explicit approach to trans-contextual guideline adap-
tation that comprises seven sequential steps (Figure 1).
Figure 1 Sequential process for the trans-contextual adaptation of guidelines.
Step Examples 
Step 1 – Definition of the clinical questions to be included in 
the final guideline, taking into consideration the following criteria 
(PIPOH):  
• Patient population (including disease characteristics) 
Intervention(s) of interest 
• Professionals/patients (audience for whom the guideline is 
prepared) 
• Outcomes to be taken into consideration (purpose of the 
guideline) 
• Healthcare setting and context 
Guidelines on colon cancer 
treatment 
• Adult population 
• Chemotherapy 
• Medical oncologists 
 
• Survival, quality of life 
 
• Secondary & tertiary care 
 
Step 2 - Search for source guidelines: 
• Use guideline resource databases, websites of guideline 
developing organisations, bibliographic databases and 
search engines.  
• Define and use search criteria like language, date of 
publication and type of publisher.  
• Use population (P) and intervention (I) terms in the search 
strategy. 
 
Use of  
1. general databases (e.g., NGC, 
G-I-N, NICE)*, and  
2. cancer related sources (e.g., 
NCCN, ASCO, SOR-FNCLCC)* 
Step 3 - Assess clinical content of the source guidelines:  
• Compare the clinical questions covered by the guidelines 
with the clinical questions of interest as defined in step 1.  
• Lack of specific guidelines for 
elderly patients and of 3rd line 
chemotherapy recommendations 
Step 4 - Evaluation of the quality and coherence of the 
source guidelines: 
• Evaluate global quality (AGREE instrument)  
• Evaluate methods for studies research and selection  
• Evaluate, for each clinical question to be included in the 
final guideline: 
o currency of the literature search  
o coherence between evidence and recommendations  
o applicability and acceptability of the recommendations to 
the context of use  
• Use of 4/6 subscales of AGREE 
(shorter and avoids redundancy) 
• Use of ad hoc questionnaire to 
examine appropriateness of 
compared chemotherapy 
regimens, control of bias, 
directness of evidence in studies 
quoted by CPGs 
• Availability of resources and 
interventions (e.g. drug licence) 
Step 5 – Adaptation of the recommendations:  
• For each clinical question, adaptation will vary in intensity: 
from adoption as is, through translation, reformulation (with 
justifications), reformatting, literature update to de novo 
development 
• Use of ad hoc questionnaire to 
examine systematically the 
application of each treatment in 
the new context  
 
Step 6 - External review of the adapted guideline:  
(similar as in guideline development de novo) 
• Experts belonging to a regional 
network of oncologists 
Step 7 – Adoption, endorsement and implementation of the 
adapted guideline 
(Similar as for de novo guideline development) 
 
• Provincial network for cancer 
treatment 
* NGC: National Guidelines Clearinghouse; G-I-N: Guidelines International Guidelines; NICE: National Cancer 
Institute; NCCN: National Comprehensive Cancer Institute; ASCO: American Society of Clinical Oncology; SOR-
FNCLCC: Standards, Options, Recommandations – Fédération Nationale des Centres de Lutte Contre le Cancer 
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(i) Definition of the clinical questions: The process has a similar
starting point as that for de novo development of guidelines,
after having identified the need for the guideline and having
established a multidisciplinary working group. The clinical
questions should be defined, taking into consideration the
following criteria: Patient population (including disease char-
acteristics) Intervention(s) of interest, the Professionals to
whom the guideline will be targeted, health Outcome(s) of
interest, and the Health care setting in which the adapted
guideline will be used (PIPOH).
(ii) Search for source guidelines: When guideline adaptation is
used as an alternative to de novo development, we recom-
mend performing a search for source guidelines to identify all
the most relevant guidelines for adaptation. Because many
guidelines are not published in medical journals, and not
indexed in bibliographic databases, the search should start in
guideline clearinghouses, such as the National Guideline
Clearinghouse, the Guidelines International Network, or in
country-specific databases such as the French Guideline
Clearinghouse or the German database of the Agency for
Quality in Medicine. In addition, websites of organizations
developing guidelines and medical speciality societies can be
consulted. Search engines (e.g. Google, AltaVista, and Yahoo)
can be helpful, particularly for searching guidelines on rare
topics. Searching in Medline using a standardized search strat-
egy may yield additional guidelines: guideline [Publication
Type] or practice guideline [Publication Type], or recommen-
dation* [Title] or standard* [Title] or guideline* [Title], in
combination with terms related to the clinical topic.
(iii) Assessment of clinical content in the source guidelines: The
retrieved guidelines should then be assessed to ensure that
they correspond to the clinical questions to be answered (in
terms of the population and interventions), to select those
that should be included in a more detailed assessment. If the
retrieved guidelines do not cover the clinical questions
defined in step 1, it may be necessary to revise or clarify these
or to accept that there are no existing guidelines covering the
questions of interest. In this latter case, it may be necessary to
assess the need to produce a specific de novo guideline.
(iv) Assessment of the quality and coherence of the source guidelines:
This is a pivotal step in the adaptation process and should
involve assessment of three aspects: quality of reporting,
internal validity (i.e. consistency between the recommenda-
tions and the evidence cited), and applicability of the recom-
mendations to the context of use. The AGREE instrument is
becoming a widely accepted standard for assessing the meth-
odological quality and reporting of guidelines [7]. However, a
well-reported guideline can contain flawed recommendations.
To have confidence in the recommendations, the assessment
should also include the evaluation of the methods used to
search and select the evidence, including the databases
searched, the search strategies used, the selection criteria
used, the method used to select the evidence, and how many
references were found, included, and excluded. The method-
ological and clinical consistency between the evidence cited
and the conclusions of the critical appraisal of this evidence
should include the assessment of the appropriateness of the
study settings, the study protocols, and the methodological
quality of the studies. The coherence of the recommendations
with the conclusions should involve an assessment of the
directness of the evidence and the consistency of the strength
of the recommendation, with the level of evidence of the
included studies. This evaluation requires the participation of
both clinical experts and guideline methodologists. Finally,
the applicability and acceptability of the recommendations to
the context of use in the target country, region, or local set-
ting should be assessed and then discussed in detail with the
working group. This should involve an assessment of the
availability of the intervention and expertise, access to and
quality of services, legal and resource constraints, as well as
differences in cultural values and potential acceptance of
intervention by the target population.
(v) Adaptation of the recommendations: Summarizing the
information from the above assessments (quality scores,
coherence between evidence and recommendations, and
applicability of specific recommendations) for each of the
selected guidelines in a comparative table will facilitate the
selection of relevant source guidelines and the identification
of recommendations that can be adopted and those that will
require modification.
The degree of adaptation may involve adoption of the
guideline, without changing the content, or adaptation of all
or part of one or several source guidelines, or development of
a new guideline, where the source guidelines serve as a start-
ing point, depending on the guideline topic, context, and cur-
rency. The time and resources needed depend on the number
of source guidelines selected, their quality and their currency,
and the extent of any differences in the cultural and organiza-
tional features between the context of the source guidelines
and targeted context.
(vi ) External review of the adapted guideline: Before its dissemi-
nation and implementation, the adapted guideline should
undergo external review, which is also recommended in the
process of development of a de novo guideline. The com-
ments and suggestions from this external review should be
addressed, either by modifying the guideline or by giving rea-
sons for not taking them into account.
(vii ) Adoption, endorsement, and implementation of adapted guide-
line: Once the guideline has been adapted and endorsed, a
strategy of implementation should be put into action, if this is
one of the missions of the organization that has adapted the
guideline. If it is not their mission, then the target users will
have to undertake this step.
Discussion
Most important clinical topics have already been addressed in
guidelines produced somewhere in the world. Because the key
methods for guideline development have converged over the
years, and most organizations have limited resources, there is
an increasing interest in adapting existing guidelines. Several
authors suggest that adapting guidelines, rather than de novo
development, could contribute to reducing unnecessary
duplication of effort [19,26,27]. Our review of the literature
has confirmed this increasing interest in adapting guidelines,
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which is highlighted by the fact that the majority of retrieved
papers were published in 2000 or later. Many guidelines
groups have recognized the importance of adapting guide-
lines, particularly in terms of avoiding unnecessary duplica-
tion of effort, for example, the Canadian Strategy for Cancer
Control and the New Zealand Guidelines Group. In addition,
the Registered Nurses Association of Ontario is probably the
only organization to have a guideline policy, which is based
on the adaptation of existing guidelines only, with no de novo
guideline development.
Adaptation of guidelines is performed at different stages of
the guideline development process. In four reports, it has
been used as an alternative to de novo guideline development
[18,23–25], and in many others, it is used as a means of
improving guideline implementation, through local tailoring
of an international or national guideline, involving trans-
contextual and trans-cultural adaptation and/or modification
of the format. Although the objectives differ slightly, both types
of adaptation aim at tailoring guidelines to make them more rel-
evant to the context in which they will be implemented.
The translation of evidence into guideline recommenda-
tions should take into consideration the organizational and
cultural context in which the evidence will be interpreted and
implemented, particularly when the evidence is weak or
sparse [41]. The type and quality of the evidence on which the
recommendations are based can vary, depending on the exact
clinical questions addressed and when and how the search for
evidence is performed. For example, the dates covered by the
strategies and the use of restriction criteria, such as language,
can often explain this variation. This, in combination with dif-
ferences in culture and context, can lead to legitimate and/or
explainable variations in guideline recommendations, without
necessary involving any methodological problems. Therefore,
the applicability of the guideline recommendations in the tar-
get context, and the degree to which a source guideline needs
adaptation is dependent on the differences in the organiza-
tional, legislative, and cultural contexts. These considerations
include the availability of diagnostic, treatment, and other
health services, the organization of the health services, the
expertise and resources as well as cultural beliefs and value
judgements, patient preferences, and population characteris-
tics (or prevalence of disease) [20–22,26–33]. Translation
from one language to another, which is important for the
implementation of guidelines produced elsewhere, could be
considered as a form of cultural adaptation of the guideline.
Trans-contextual guideline adaptation should ensure that
the adapted guidelines answer specific clinical questions relev-
ant for the context of use and that it replies to the needs, prior-
ities, legislation, policies, and resources in the targeted setting,
without threatening the quality and validity of the guidelines. A
multidisciplinary group is important in this process, not only
to enhance the relevance for local practice but also to foster
broad ownership and uptake of the adapted guideline
[31,35,36,39]. The more the recommendations in the source
guidelines are based on expert opinion, in the absence of a
high level of evidence, the more a formal process (such as
nominal group techniques, or methods based on the Delphi
approach) will be required for adapting the recommendations
to increase the transparency of expert judgement [26,32].
These formal methods could also be useful for taking into
consideration context variables when adapting guidelines for
culturally-sensitive interventions [20–22].
Adaptation of existing guidelines will respect the evidence-
based approach and should improve the quality and consist-
ency of the guidelines produced. This approach could be
more beneficial for countries and organizations with small
budgets and limited experience, although it is probably also
true for larger, better resourced and more experienced organi-
zations. Currently, there is no evidence suggesting that guide-
line adaptation will increase the efficiency of guideline
production or reduce costs, compared with de novo guideline
development. However, adaptation will have to overcome
certain difficulties such as heterogeneous quality, insufficient
transparency in the reporting for guidelines, and the currency
of the guidelines. If organizations produce adapted guidelines,
they should also include in their process a means of checking
the currency of their guidelines. Although several publications
propose methods for this assessment, there is no validated
method at present. One possible spin-off from the adaptation
process could be that other organizations could be offered
timely and easy access to the updated guidelines, although the
modality of this sharing process would need to be developed.
Further research is needed to assess the advantages of adapta-
tion of guidelines, in comparison with de novo development.
In addition, our approach to guideline adaptation provides
an excellent opportunity to include an appropriate implemen-
tation step at the beginning of the process, by the explicit
consideration of the context of use and the potential organi-
zational or cultural barriers to changing current practice. This
includes taking into consideration ownership and adherence
issues for the guideline’s target users.
One limitation of our study is the lack of specific indexa-
tion of this type of research in the main bibliographic data-
bases. The literature search strategy that was developed had a
low specificity; however, although the percentage of relevant
papers identified was low (1.7%), we probably identified all
the relevant reports. Another limitation is the need to validate
the proposed process of guideline adaptation through field-
testing. We are planning several such studies to refine and val-
idate the process for guideline adaptation with guideline
developers in different countries. The first study will involve a
formal external review of the proposed adaptation process
(described in a manual) by guideline methodologists. Then
the manual will be used in field feasibility studies as part of a
multicentre international validation study.
Trans-contextual guideline adaptation will provide an
excellent opportunity to improve our understanding of how
context variables, such as culture, organization of care and
societal values, influence the translation of evidence into rec-
ommendations for clinical practice. Moreover, this approach
will facilitate cooperation between organizations developing
guidelines and encourage them to explore common strategies
for sharing development of guidelines at an international level
to avoid duplication of effort and to define which aspects
require specific national or local input. Further research is
needed to evaluate, formally, the adaptation process that we
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propose, particularly its advantages compared with de novo
development.
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